Benzinga | Aug 3, 2020 04:26PM EDT

Aduro Biotech Q2 EPS $(0.21) Up From $(0.23) YoY, Sales $5.57M Up From $4.89M YoY

Aduro Biotech (NASDAQ:ADRO) reported quarterly losses of $(0.21) per share. This is a 8.7 percent increase over losses of $(0.23) per share from the same period last year. The company reported $5.57 million in sales this quarter. This is a 14.03 percent increase over sales of $4.89 million the same period last year.